Clinical trial Recruiting at 1 site Observational Ages 5 to 16

Assessing the impact of airway allergic diseases on children's and parents' quality of life

Official title: The Impact of Airway Allergic Diseases on the Health-related Quality of Life of Children and Their Parents (Caregivers): A Prospective Controlled Study

Run by RenJi Hospital · NCT06535087 · Data updated 2026-11-12

This study looks at how having asthma or allergies affects the quality of life for children and their parents, comparing those getting special treatment to those on regular care.

More Pediatric Asthma trials

Quick facts

Study typeObservational
Ages5 Years to 16 Years
SexAll
Enrollment600 (estimated)
SponsorRenJi Hospital
Academic / other
Drugs / interventionsimmunotherapy
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedJuly 20, 2024
Main results expectedJune 23, 2025
Study endsMay 31, 2027
Registry record updatedAugust 2, 2024
Trial IDNCT06535087 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include children aged 5-16 diagnosed with bronchial asthma, allergic rhinitis, or both, along with their primary caregivers.

Probably not a fit

Patients who have already received specific immunotherapy at another hospital or those unable to complete the questionnaires may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the health-related quality of life (HRQoL) of 200 children aged 5-16 with bronchial asthma, allergic rhinitis, or both, alongside their parents. It compares 100 children receiving specific immunotherapy to 100 receiving routine treatment, using validated questionnaires to assess changes in HRQoL over one and two years. A control group of 100 healthy children and their parents will also be included to analyze the impact of allergic diseases on quality of life and caregiver burden. The study aims to provide insights that could enhance clinical management and inform policy for pediatric allergic conditions.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies that enhance the quality of life for children with allergic diseases and their families.

How similar studies have gone: Previous studies have shown that allergen-specific immunotherapy can significantly improve quality of life in patients with allergic diseases, suggesting a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Children:

   1. Aged 5-16 years;
   2. Diagnosed with bronchial asthma, allergic rhinitis, or both (persistent, duration ≥4 weeks) by a respiratory or allergy specialist;
   3. Guardian has signed the informed consent form;
   4. Able to understand and complete the questionnaire;
   5. Outpatients or inpatients at the Pediatrics Department of Renji Hospital in Shanghai.
2. Parents:

   1. The primary caregiver of the enrolled child;
   2. Accompanied the child to the hospital on the day of the visit;
   3. Signed the informed consent form;
   4. Able to understand and complete the questionnaire.

Exclusion Criteria:

1. Children:

   1. Poor compliance;
   2. Already received specific immunotherapy at another hospital;
   3. Unable to independently read and complete the questionnaire;
   4. Lost to follow-up or discontinued treatment.
2. Parents:

   1. Unwilling to sign the informed consent form;
   2. Unable to complete the questionnaire due to physical condition or educational level.

Where it's running

  • Renji Hospital, School of Medicine, Shanghai Jiaotong University
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Wenjing Zhou — Renji Hospital, School of Medicine, Shanghai Jiaotong University
  • Study coordinator: Wenjing Zhou
  • Email: zhoujing2188@163.com
  • Phone: +31685281032

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.